Stay updated with breaking news from B1 2bn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inhibrx announced an agreement with Sanofi on Tuesday, under which Sanofi subsidiary Aventis will acquire all assets and liabilities associated with INBRX-101, a recombinant alpha-1 antitrypsin (AAT) augmentation therapy currently being trialled for alpha-1 antitrypsin deficiency (AATD) treatment.
AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.
Chinese electric car maker Nio said on Monday that Abu Dhabi-backed fund CYVN Holdings will invest a further $2.2bn in the loss-making company.
Dailymirror.lk – Sri Lanka 24 Hours Online Breaking News : News, Politics, Video, Finance, Business, Sports, Entertainment, Travel, sri lanka news,sri lanka latest news, latest breaking news, latest political news, covid-19 news,covid-19 news sri lanka, Sri Lanka Coronavirus updates, sl news, sl covid-19 news, SL breaking news, daily news, breaking news in sri lanka
BANGKOK: In partnership with KBank Private Banking (KBank) and UOB Asset Management Thailand (UOBAM), HOMA has announced the successful closing of United Private Equity Fund 1 (not for retail investor